Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (26)

2023

  1. Ivabradine for controlling heart rate in permanent atrial fibrillation: A translational clinical trial

    Heart rhythm, Vol. 20, Núm. 6, pp. 822-830

2020

  1. The p.P888L SAP97 polymorphism increases the transient outward current (Ito,f) and abbreviates the action potential duration and the QT interval

    Scientific Reports, Vol. 10, Núm. 1

2016

  1. Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Núm. 46, pp. E7250-E7259

2012

  1. Plasma desmoplakin I biomarker of vascular recurrence after ischemic stroke

    Journal of Neurochemistry, Vol. 121, Núm. 2, pp. 314-325

2011

  1. Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats

    Hypertension, Vol. 58, Núm. 4, pp. 733-743

  2. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats

    British Journal of Nutrition, Vol. 106, Núm. 9, pp. 1337-1348

  3. Proteomic changes related to "bewildered" circulating platelets in the acute coronary syndrome

    Proteomics, Vol. 11, Núm. 16, pp. 3335-3348

2010

  1. Antihypertensive efficacy and tolerability oflercanidipine in daily clinical practice. The ELYPSE study

    Russian Journal of Cardiology, Vol. 84, Núm. 4, pp. 72-77

  2. Comparative expression of proteins in left and right atrial appendages from patients with mitral valve disease at sinus rhythm and atrial fibrillation

    Journal of Cardiovascular Electrophysiology, Vol. 21, Núm. 8, pp. 859-868

  3. Old and new molecular mechanisms associated with platelet resistance to antithrombotics

    Pharmaceutical Research, Vol. 27, Núm. 11, pp. 2365-2373

2009

  1. Omecamtiv mecarbil. Cardiac myosin activator treatment of heart failure

    Drugs of the Future, Vol. 34, Núm. 12, pp. 950-961

2008

  1. Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients

    Proteomics - Clinical Applications, Vol. 2, Núm. 9, pp. 1300-1312

  2. Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1)

    Cardiovascular Research, Vol. 80, Núm. 3, pp. 375-384

  3. The HERACLES cardiovascular network

    Revista Espanola de Cardiologia, Vol. 61, Núm. 1, pp. 66-75

2006

  1. Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism

    Cardiovascular Research, Vol. 72, Núm. 1, pp. 80-89

  2. Proteomic study of plasma from moderate hypercholesterolemic patients

    Journal of Proteome Research, Vol. 5, Núm. 9, pp. 2301-2308

2005

  1. Soluble guanylyl cyclase during postnatal porcine pulmonary maturation

    American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 288, Núm. 1 32-1

2004

  1. Blood pressure control and physician physician management of hypertension in hospital hypertension units in Spain

    Hypertension, Vol. 43, Núm. 6, pp. 1338-1344

2002

  1. Hypertension magnitude and management in the elderly population of Spain

    Journal of Hypertension, Vol. 20, Núm. 11, pp. 2157-2164

1997

  1. Endothelium-derived nitric oxide-dependent response to hypoxia in piglet intrapulmonary arteries

    BIOLOGY OF THE NEONATE, Vol. 72, Núm. 1, pp. 62-70